Alert detail
LCD L38586: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer — CGS Administrators
Policy ID: LCD-L38586Specialty: OncologyAdded: 6/5/2026Effective: 2026-05-21lcd
What changed
New LCD for molecular classifiers in bladder cancer testing.
Who’s affected: Oncology billing teams · Effective: 2026-05-21
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.
Not ready to subscribe?
Get the free weekly reimbursement brief for Oncology— the week’s changes and deadlines, delivered to your inbox. No account required.